This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Express Scripts Research Shows Prescription Drug Utilization Declines For Payers Of Workers' Compensation

Stocks in this article: ESRX









ST. LOUIS, April 22, 2013 /PRNewswire/ -- Express Scripts' (NASDAQ: ESRX) industry-leading prescription management programs drove down utilization of prescription drugs for workers' compensation payers last year even though overall drug trend rose, according to new research released today in the Express Scripts 2012 Workers' Compensation Drug Trend Report.

(Logo:  http://photos.prnewswire.com/prnh/20080827/EXPRESSSCRIPTSLOGO)

Narcotic analgesics, which once again accounted for the highest spend among therapy classes in workers' compensation, saw utilization decline 2.7 percent. OxyContin ®, which accounted for nearly 10 percent of the total drug spend, had a 6.1 percent drop in utilization, although at $132.50, it still represents the highest average cost per user.

Overall trend — a combination of spending on drugs and utilization of drugs — increased 2.9 percent in 2012, reversing two years of declines, driven primarily by a 10 percent increase in cost per user for antidepressants and dermatologicals, such as Lidoderm™, Flector™ and Voltaren™. Availability of new products or new product indications in the two classes greatly affected trend.

Tim Pokorney, pharmacist, and clinical director of workers' compensation at Express Scripts, noted that the findings demonstrate the need for effective prescription-drug management programs for workers' compensation payers.

"Payers need innovative solutions that help them drive the use of clinically equivalent, cost-effective generics that can help rein in their overall pharmacy spending," Pokorney said. "Express Scripts is uniquely positioned to offer payers better solutions by bringing together our complementary capabilities of the behavioral sciences, clinical specialization and actionable data."

Programs that help control utilization include Oral Fentanyl Intervention and Long-Acting Narcotics outreach to physicians. Express Scripts also offers step therapy, narcotics education for injured workers and physicians, Drug Utilization Review, Physician Peer-to-Peer, and formulary management programs.

One product that helps manage trend for clients is a communication program that encourages injured workers to use lower-cost generic equivalents. The product is based on the findings of an Express Scripts research pilot which demonstrated how injured workers who received a letter explaining how their prescription drug choices could help control the rising cost of healthcare were 60% more likely to choose a generic equivalent.

1 of 3

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,804.80 +26.65 0.15%
S&P 500 2,070.65 +9.42 0.46%
NASDAQ 4,765.38 +16.9840 0.36%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs